Ukraine officially introduced the “Compassionate Use” program several years ago, following the adoption of bill No. 5736.

Thus patients with serious illnesses, including those suffering from oncology and orphan diseases, to access medications that are still in clinical trials. This mechanism allows pharmaceutical companies to provide these drugs for free to a limited number of patients, even if they are not yet registered in Ukraine, as long as they have passed at least phase II of clinical trials.

⭐It expands access to innovative treatments in Ukraine that have shown effectiveness in clinical trials but are not yet available on the market.

⭐Pharmaxi, as a full-service CRO with extensive experience in clinical studies, is well-versed in conducting such trials, ensuring that these critical programs run smoothly, providing patients with the opportunity to receive potentially life-saving treatments.

The program continues to operate under approved rules and procedures, enabling patients to access the care they need.

We look forward to your requests!